Journal Information
Vol. 38. Issue 5.
Pages 236-245 (May 2002)
Share
Share
Download PDF
More article options
Vol. 38. Issue 5.
Pages 236-245 (May 2002)
Full text access
Tos crónica
Visits
60582
A. De Diego Damiá, V. Plaza Moral, V. Garrigues Gil, J.L. Izquierdo Alonso, A. López Viña, J. Mullol Miret, A. Pereira Vega
This item has received
Article information
Full text is only aviable in PDF
Bibliografía
[1.]
Pediatrics American Academy of.
Involuntary smoking: hazard to children.
Pediatrics, 77 (1986), pp. 755-757
[2.]
M. Aylward, Maddock, D.E. Davies, et al.
Dextromethorphan and codeine: comparison of plasma kinetics and antitussive effects.
Eur J Respir Dis, 65 (1984), pp. 283-291
[3.]
J.A. Barberá, G. Peces-Barba, A. Agustí, et al.
Guía clínica para el diagnóstico y tratamiento de la enfermedad pulmonar obstruciva crónica.
Arch Bronconeumol, 37 (2001), pp. 297-316
[4.]
Bardagí, Calvo, Casan, De Diego, Cimas, Hernández, et al.
Recomendaciones (SEPAR-semFYC) para la atención del paciente con Asma.
Arch Bronconeumol, 34 (1998), pp. 394-399
[5.]
A.F. Barker, E.J. Bardana.
Bronchiectasis: update on an orphan disease.
Am Rev Respir Dis, 137 (1988), pp. 969-978
[6.]
W.D. Bennet, W.F. Chapman, J.M. Mascrarella.
The acute effect of ipratropium bromide bronchodilator therapy on cough clearance in COPD.
Chest, 103 (1993), pp. 488-495
[7.]
K.E. Berkin.
Respiratory effects of angiotensin converting enzyme inhibition.
Eur Respir J, 2 (1989), pp. 198-201
[8.]
S. Blazer, Y. Nevah, A. Friedman.
Foreign body in the airway.
Am J Dis Child, 134 (1980), pp. 68-71
[9.]
C.E. Brightling, R. Ward, K.L. Goh, et al.
Eosinophilic Bronchitis is an important cause of chronic cough.
Am J Respir Crit Care Med, 160 (1999), pp. 406-410
[10.]
C.E. Brightling, G. Woltmann, A.J. Wardlaw, I.D. Pavord.
The development of irreversible airflow obstrucction in a patient with eosinophilic bronchitis whitout asthma.
Eur Respir J, 14 (1999), pp. 1228-1230
[11.]
C.E. Brightling, R. Ward, G. Woltmann, P. Bradding, J.R. Sheller, R. Dworski, et al.
Induced sputum inflammatory mediator concentrations in eosinophillic bronchitis and asthma.
Am J Respir Crit Care Med, 162 (2000), pp. 878-882
[12.]
T.C.K. Brown, C.M. Clark.
Inhaled foreign bodies in children.
Med J Aust, 2 (1983), pp. 322-326
[13.]
C. Bucca, G. Rolla, L. Brusino, V. De Rose, M. Bugiani.
Are asthmalike symptoms due to bronchial or extrathoracic airway dysfunction?.
Lancet, 346 (1995), pp. 791-795
[14.]
S. Cheriyan, P.A. Grenberger, P.A. Patterson, R. Patterson.
Outcome ofcougt variant asthma treated with inhaled steroids.
Ann Allergy, 73 (1994), pp. 478-480
[15.]
F.J. Curley, R.S. Irwin, M.R. Pratter, et al.
Cough and the common cold.
Am Rev Respir Dis, 138 (1988), pp. 305-311
[16.]
F.J. Curley, R.S. Irwin.
Chronic cough.
Current diagnosis, 8th ed, pp. 16-20
[17.]
S.F. Davis, R.W. Sutter, P.M. Strebel, et al.
Concurrent outbreaks of pertussis and mycoplasma pneumoniae infection: clinical and epidemiological characteristics of illnesses manifested by cough.
Clin Infect Dis, 20 (1995), pp. 621-628
[18.]
F.M. De Benecdictis, G.J. Canny, H. Levison.
Methacholine inhalation challenge in the evaluation of chronic cough.
J Asthma, 23 (1986), pp. 303-308
[19.]
T. Doan, R. Patterson, P.A. Greenberger.
Cough variant asthma: usefulness of a diagnostic therapeutic trial with prednisone.
Ann Allergy, 69 (1992), pp. 505-509
[20.]
J.M. Fitzgerald, C.J. Allen, M.A. Craven, M.T. Newhouse.
Chronic cough and gastroesophageal reflux.
Can Med Assoc J, 140 (1989), pp. 520-524
[21.]
R. Fogari, A. Zoppi, F. Tettamanti, et al.
Effects of nifedipine and indomethacin on cough induced by angiotensin-convering enzyme inhibitors: a double-blind, randomized, cross-over study.
J Cardiovasc Pharmacol, 19 (1992), pp. 670-673
[22.]
R.W. Fuller.
Cough associated with angiotensin convertingenzyme inhibitors.
J Hum Hypertens, 3 (1989), pp. 159-161
[23.]
W.D. Ghafouri, K.D. Patil, K. Irwing.
Sputum changes associated with the use of ipratropium bromide.
Chest, 86 (1984), pp. 387-393
[24.]
P.G. Gibson, J. Dolovich, J. Denburg, et al.
Chronic cough: eosinophilic bronchitis without asthma.
Lancet, 1 (1989), pp. 1346-1348
[25.]
P.G. Gibson, F.E. Haergreave, A. Girgis-Gabardo, M. Morris, J.A. Denburg, J. Dolovich.
Chronic cough with eosinophilic bronchitis: examination for variable airflow obstruction and response to corticosteroid.
Clin Exp Allergy, 25 (1995), pp. 127-132
[26.]
Grupo de trabajo de SEPAR.
Normativa asctualizada (1998) sobre diagnóstico y estadificación del carcinoma broncogénico.
Arch Bronconeumol, 34 (1998), pp. 437-452
[27.]
F. Hargreave, R. Leigh.
Induced sputum, eosinophillic bronchitis and chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 160 (1999), pp. S53-S57
[28.]
M.R. Hargreaves, M.K. Benson.
Inhaled sodium cromoglycate in angiotensin- converting enzyme inhibitor cough.
Lancet, 345 (1995), pp. 13-15
[29.]
S.L. Hill, D. Burnett, K.A. Hewetson, et al.
The response of patients with purulent bronchiectasis to antibiotics for four months.
Q J Med, 66 (1988), pp. 163-173
[30.]
V. Hoffstein.
Persistent cough in nonsmokers.
Can Respir J, 1 (1994), pp. 40-47
[31.]
L.D. Holinger, A.D. Sanders.
Chronic cough in infants and children; an update.
Laringoscope, 101 (1991), pp. 596-605
[32.]
P.W. Holmes, C.E. Barter, R.J. Pierce.
Chronic persistent cough: use of ipratropium bromide in undiagnosed cases following upper respiratory tract infection.
Respir Med, 86 (1992), pp. 425-429
[33.]
E. Houtmeyers, R. Gosselink, Gayan Ramírez, M. Decramer.
Effects of drugs on mucus clearance.
Eur Respir J, 14 (1999), pp. 452-467
[34.]
R.S. Irwin, L.P. Boulet, M.M. Cloutier, R. Fuller, P.M. Gold, V. Hoffstein, et al.
Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians.
Chest, 114 (1998), pp. S133-S181
[35.]
R.S. Irwin, W.M. Corrao, M.R. Pratter.
Chronic persistent cough in the adult: the spectrum and frequency of causes and succesful outcome of specific therapy.
Am Rev Respir Dis, 123 (1981), pp. 413-417
[36.]
R.S. Irwin, F.J. Curley, F.M. Bennett.
Appropiate use of antitussives and protussives. A practical review.
Drugs, 46 (1993), pp. 80-91
[37.]
R.S. Irwin, F.J. Curley, C.L. French.
Chronic cough: the spectrum and frequency of causes, key components of the diagnostic evaluation and outcomes of specific therapy.
Am Rev Respir Dis, 141 (1990), pp. 640-647
[38.]
R.S. Irwin, F.J. Curley.
The treatment of cough, a comprehensive review.
Chest, 99 (1991), pp. 1477-1484
[39.]
R.S. Irwin, J.K. Zawacki, F.J. Curley, C.L. French, P.J. Hoffman.
Chronic cough as the sole presenting manifestation of gastroesophageal reflux.
Am Rev Respir Dis, 140 (1989), pp. 1294-1300
[40.]
C.A. Jiménez, S. Solano, J.M. González de la Vega, et al.
Normativa para el tratamiento del tabaquismo.
Arch Bronconeumol, 35 (1999), pp. 499-506
[41.]
D. Johnson, L.M. Osborne.
Cough variant asthma: a review of the clinical literature.
J Asthma, 28 (1991), pp. 85-90
[42.]
Z. Joomaye, A. Sotto, J. Jourdan.
Isolated prolonged cough caused by Horton's disease.
Rev Mal Respir, 14 (1997), pp. 59-60
[43.]
P.J. Kahrilas, E.M.M. Quigley.
Clinical esophageal pH recording: a technical review for practice guideline development.
Gastroenterology, 110 (1996), pp. 1982-1996
[44.]
A.G. Klauser, N.E. Schindlbeck, S.A. Müller-Lissner.
Symptoms in gastro-oesophageal reflux disease.
Lancet, 335 (1990), pp. 205-208
[45.]
Y. Lacourciere, H. Brunner, R. Irwin, et al.
Effects of modulators of the renin-angiotensin-aldosterone system on cough: Losartan Cough Study Group.
J Hypertens, 12 (1994), pp. 1387-1393
[46.]
T.S. Larson, S. Hall, N.G. Hepper, G.G. Hunder.
Respiratory tract symptoms as clue to giant cell arteritis.
Ann Intern Med, 101 (1984), pp. 594-597
[47.]
M. León, E. Cases, C. Rogado, M. Martínez, N. Pérez.
Características de la demanda asistencial en la consulta ambulatoria de neumología del área 12 y 13 de Valencia durante el año 1994.
Arch Bronconeumol, 31 (1995), pp. 86
[48.]
T. Lidholdt, H. Rundcrantz, M. Bende, K. Larsen.
Glucocorticoid treatment for nasal polyps. The use of topical budesonide powder, intramuscular betamethasone, and surgical treatment.
Arch Otolaryngol Head Neck Surg, 123 (1997), pp. 595-600
[49.]
P.L. Malini, E. Strocchi, M. Zanardi, et al.
Thromboxane antagonism and cough induced by angitensin-converting-enzyme inhibitor.
[50.]
L.M. Marmon, M.R. Bye, J.M. Haas, et al.
Vascular rings and sling: long-term follow-up of pulmonary function.
J Pediatr Sur, 68 (1984), pp. 683-690
[51.]
F.D. McCool, D.E. Leith.
Pathophysiology of cough.
Clin Chest Med, (1987), pp. 189-195
[52.]
J.R. McEwan, N.B. Choudry, R.W. Fuller.
The effect of sulindac on the abnormal cough reflex assciated with dry cough.
J Pharmacol Exp Ther, 255 (1990), pp. 161-164
[53.]
L.P.A. McGarvey, L.G. Heaney, M. Ennis.
McMahon. Chronic cough.
Thorax, 54 (1999), pp. 563
[54.]
C.J. Mello, R.S. Irwin, F.J. Curley.
The predictive values of the character, timing and complications of chronic cough in diagnosing its cause.
Arch Intern Med, 156 (1996), pp. 997-1003
[55.]
W.j. Morgan, L.M. Taussg.
The child with persistent cough.
Pediatr Rev, 8 (1987), pp. 49-53
[56.]
J. Mullol.
Rinitis alérgica en el año 2000. Clasificación y tratamiento actualizados [en prensa].
Arch Bronconeumol, (2000),
[57.]
North American Tilade Study Group.
A duble-blind multicenter group comparative study of the efficacy and safety of nedocromil sodium in the management of asthma.
Chest, 97 (1990), pp. 299-306
[58.]
E.J. O'Connell, A.R. Rojas.
Sachs MI: Cough-type asthma, a review.
Ann Allergy, 66 (1991), pp. 278-286
[59.]
P.M. O'Byrne, L. Cuddy, D.W. Taylor, et al.
The clinical efficacy and cost benefit of inhaled corticostteroids as therapy in patients with mild asthma in primary care practice.
Can Respir J, 3 (1996), pp. 169-175
[60.]
S.R. Orenstein, T.M. Shalaby, P.E. Putmam.
Thickened feedings as a cause of increased coughing when used as therapy for gastroesophageal reflux in infants.
J Pediatr, 121 (1992), pp. 913-915
[61.]
D. Pavía, J.E. Agnew, J.M. Glassman, et al.
Effects of iodopropylidine glycerol on tracheobronchial clearance in stable chronic bronchitis patients.
Eur J Respir Dis, 67 (1985), pp. 177-184
[62.]
P.A. Pedersen, E.R. Weeke.
Asthma and allergic rhinitis in the same patients.
Allergy, 38 (1983), pp. 25
[63.]
T.L. Petty.
The national mucolytic study: results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis.
Chest, 97 (1990), pp. 75-83
[64.]
V. Plaza, G.R. Trigo, M. Peiró, S. Fernández, N. Barragán, D. Ferrer-Vidal, et al.
Grado de satisfacción de los médicos de Atención Primaria (AP) y pacientes sobre un nuevo esquema asistencial neumológico extrahospitalario [en prensa].
Arch Bronconeumol, (2001),
[65.]
V. Plaza, I. Solanes, J. Serra-Batlles, A. Escartín.
Chronic persitent cough due to Gilles de la Tourette's syndrome.
Respiration, 66 (1999), pp. 380
[66.]
R.H. Poe, R.V. Harder, R.H. Israel, M.C. Kallay.
Chronic persistent cough: experience in diagnosis and outcome using an anatomic diagnostic protocol.
Chest, 95 (1989), pp. 723-738
[67.]
R.H. Poe, R.H. Israel, M.J. Utell, et al.
Chronic cough: Bronchoscopy or pulmonary function testing?.
Am Rev Respir Dis, 126 (1982), pp. 160-162
[68.]
R.H. Poe, R.H. Israel.
Chronic cough: a strategy for work-up and therapy.
J Respir Dis, 18 (1997), pp. 629-641
[69.]
PSNP (Position statement on nasal polyposis).
Rhinology, 32 (1994), pp. 126
[70.]
M.R. Pratter, T. Bartter, S. Akers, et al.
An algorithmic approach to chronic cough.
Ann Intern Med, 119 (1993), pp. 977-983
[71.]
J. Sanhis, P. Casan, J. Castillo, N. González, L. Palenciano, J. Roca.
Normativa para la práctica de la espirometría forzada.
Arch Bronconeumol, 25 (1989), pp. 132-142
[72.]
K.G. Scadding, J.W. Crofton, T. Anderson, et al.
Prolonged antibiotic treatment of severe bronchiectasis. A report of the antibiotics clinical trals committee of the medical research council.
BMJ, 2 (1957), pp. 225-229
[73.]
S.M. Somerville, R.J. Rona, S. Chinn.
Passive smoking and respiratory conditions in primary school children.
J Epidemiol Community Health, 42 (1988), pp. 105-110
[74.]
O.N. Tinnion, M. Hanlon.
Acellular vaccines for preventing whooping cough in children (Cochrane Review).
The Cochrane Library, Issue 2,
[75.]
United States Preventive Service Task Force.
Guide to Clinical Preventive Services, pp. 263
[76.]
A. Valencia, P. Casan, M. Díaz, M. Perpiñá, M.D. Sebastián.
Normativa de los tests de provocación bronquial inespecífica.
Arch Bronconeumol, 27 (1991), pp. 353-361
[77.]
P. Van Cauwenberge, C. Bachert, G. Passalacqua, J. Bousquet, G.W. Canonica, S.R. Durham, et al.
Consensus statement on the treatment of allergic rhinitis.
Allergy, 55 (2000), pp. 116-134
[78.]
R.E. Wood.
Localized tracheomalacia or bronchomalacia in children with intractable cough.
J Pediatr, 116 (1990), pp. 404-406
[79.]
E.L. Wynder, P.K. Kaufman, R.L. Lerrer.
A short term follow up study on excigarette smokers: with special emphasis on persistent cough and weight gain.
Am Rev Respir Dis, 96 (1967), pp. 645-655
[80.]
Zoumboulakis, D. Anagnostakis, V. Albanis, et al.
Steroids in the treatment of pertussis: a controlled clinical trial.
Arch Dis Child, 48 (1973), pp. 51-54
Copyright © 2002. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?